Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 6 | $411,636 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 10 Jan 2024 16:15 | NTLA | Intellia Therapeutics Inc | SEPP-LORENZINO LAURA | EVP, Chief Scientific Officer | 08 Jan 2024 | Sale | 667 | 29.38 | 19,596 | D |
| 10 Jan 2024 16:15 | NTLA | Intellia Therapeutics Inc | SEPP-LORENZINO LAURA | EVP, Chief Scientific Officer | 08 Jan 2024 | Sale | 1,608 | 28.66 | 46,085 | D |
| 05 Jan 2024 16:50 | NTLA | Intellia Therapeutics Inc | SEPP-LORENZINO LAURA | EVP, Chief Scientific Officer | 03 Jan 2024 | Sale | 5,532 | 29.46 | 162,973 | D |
| 06 Jan 2023 17:39 | NTLA | Intellia Therapeutics Inc | SEPP-LORENZINO LAURA | EVP, Chief Scientific Officer | 05 Jan 2023 | Sale | 689 | 39.1 | 26,940 | D |
| 06 Jan 2023 17:39 | NTLA | Intellia Therapeutics Inc | SEPP-LORENZINO LAURA | EVP, Chief Scientific Officer | 05 Jan 2023 | Sale | 1,641 | 38.22 | 62,719 | D |
| 06 Jan 2023 17:39 | NTLA | Intellia Therapeutics Inc | SEPP-LORENZINO LAURA | EVP, Chief Scientific Officer | 04 Jan 2023 | Sale | 2,508 | 37.21 | 93,323 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)